The MTX treated RA patients in remission showed differential DNA methylation at 853 CpGs in CD4+ memory T cells, and at 16 CpGs in CD4+ naïve T cells compared to healthy controls (Table 5). Here, CD4 is linked to rheumatoid arthritis.